Evidence map›Paper›PMID 33953603›Full record

ArticleInternational journal of general medicine2021

Epidemiology, Clinical Characteristics, and Outcomes of a Large Cohort of COVID-19 Outpatients in Michigan.

Alexandra Halalau, Fadi Odish, Zaid Imam, Aryana Sharrak, Evan Brickner, Paul Bumki Lee, Adam Foglesong, Adrian Michel, Inayat Gill, Lihua Qu and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of general medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Alexandra HalalauInternal Medicine Department, Beaumont Health, Royal Oak, MI, USA.ORCID 0000-0002-1805-992X
Fadi OdishSection of Gastroenterology and Hepatology, Department of Internal Medicine, Wright State University, Dayton, OH, USA.
Zaid ImamDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Beaumont Health, Royal Oak, MI, USA.
Aryana SharrakOakland University William Beaumont School of Medicine, Rochester, MI, USA.
Evan BricknerOakland University William Beaumont School of Medicine, Rochester, MI, USA.
Paul Bumki LeeOakland University William Beaumont School of Medicine, Rochester, MI, USA.ORCID 0000-0001-7866-450X
Adam FoglesongInternal Medicine Department, Beaumont Health, Royal Oak, MI, USA.
Adrian MichelInternal Medicine Department, Beaumont Health, Royal Oak, MI, USA.
Inayat GillInternal Medicine Department, Beaumont Health, Royal Oak, MI, USA.ORCID 0000-0001-5972-700X
Lihua QuOakland University William Beaumont School of Medicine, Rochester, MI, USA.
Amr E AbbasOakland University William Beaumont School of Medicine, Rochester, MI, USA.
Christopher F CarpenterInternal Medicine Department, Beaumont Health, Royal Oak, MI, USA.
Oakland University · USBeaumont Health · USWright State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMost outpatients with coronavirus disease 2019 (COVID-19) do not initially demonstrate severe features requiring hospitalization. Understanding this population's epidemiological and clinical characteristics to allow outcome anticipation is crucial in healthcare resource allocation.

methodsRetrospective, multicenter (8 hospitals) study reporting on 821 patients diagnosed with COVID-19 by real-time reverse transcriptase-polymerase chain reaction assay of nasopharyngeal swabs and discharged home to self-isolate after evaluation in emergency departments (EDs) within Beaumont Health System in March, 2020. Outcomes were collected through April 14, 2020, with a minimum of 12 day follow-up and included subsequent ED visit, admission status, and mortality.

resultsOf the 821 patients, mean age was 49.3 years (SD 15.7), 46.8% were male and 55.1% were African-American. Cough was the most frequent symptom in 78.2% of patients with a median duration of 3 days (IQR 2-7), and other symptoms included fever 62.1%, rhinorrhea or nasal congestion 35.1% and dyspnea 31.2%. ACEI/ARBs usage was reported in 28.7% patients and 34.0% had diabetes mellitus. Return to the ED for re-evaluation was reported in 19.2% of patients from whom 54.4% were admitted. The patients eventually admitted to the hospital were older (mean age 54.4 vs 48.7 years,

conclusionWe found that 80.8% of patients did not return to the ED for re-evaluation. Sending patients with COVID-19 home if they experience mild symptoms is a safe approach for most patients and might mitigate some of the financial and staffing pressures on healthcare systems.

Indexed as

COVID-19demographicsepidemiologyinfectious diseaseoutpatientSARS-CoV-2

Identifiers

PMID33953603
PMCPMC8089468
OpenAlexW3111776868

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.